| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -17.2M | 100% | $12.45 | -$214M |
| Net | -1 | -17.2M | -100% | -$214M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Peter Kolchinsky | Chief Executive Officer, Director | $13.7M | Jun 29, 2021 | ||
| Ra Capital Management, L.P. | Director | $13.7M | Jun 29, 2021 | ||
| Bvf Partners L P/Il | Former 10% Owner | -$214M | Dec 18, 2023 | ||
| Yael Margolin | Director | Dec 27, 2023 | |||
| Bridget Martell | Director | Jun 13, 2023 | |||
| Gerald L. Hogue | Director | Dec 26, 2023 | |||
| Jessica D. Jensen | EVP Clinical Development | Dec 27, 2023 | |||
| Joe A. Mccann | Chief Executive Officer, Director | Dec 22, 2023 | |||
| Justyna Kelly | Chief Operating Officer | Dec 27, 2023 | |||
| Michael M. Gottlieb | Chief Commercial Officer | Jul 6, 2021 | |||
| William L. Demers | Chief Financial Officer | Dec 27, 2023 | |||
| Neil E. Fleshner | Chief Medical Officer, Director | Dec 22, 2023 | |||
| Jonathan R. Goodman | Director | Dec 26, 2023 | |||
| Rajesh Malik | Director | Dec 26, 2023 | |||
| David Lubner | Director | Dec 26, 2023 | |||
| Margaret E. Gilmour | Director | Jul 6, 2021 | |||
| Allan C. Silber | Executive Chairman, Director | Dec 22, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|